	Targeted axillary dissection in breast cancer patients: a systematic review and meta-analysis. NPJ Breast Cancer Abdelaziz MN, Mohamed SOO, Nagi MH, Alawadi IS, Mohsen Y, Ibrahim SE, Abdelsattar RM, Abdelaziz AN, Yasser M, Wael S, Abdelgawad HA, Shehab M, Abdelwahab KM, Hamdy O. PMID: 42248889 [PubMed]
	Clinical relevance of CA125 in low-grade serous ovarian cancer: a retrospective multi-center JAGO/NOGGO study. Int J Gynecol Cancer Flethe C, Netkova-Heintzen M, Postl M, Tascón Padrón L, Tauber C, Sieghartsleitner E, Pruss M, Kohlen M, Aigner A, Grech C, Pietzner K, Stroisch F, Sehouli J. PMID: 42248787 [PubMed - as supplied by publisher]
	PRS-BC(313) integration for tailored breast cancer prevention in female patients and their healthy relatives. J Med Genet Krakowsky RHE, Drukewitz S, Händel A, Wiedenhöft J, Aktas B, Lemke JR, Strehlow V, Hentschel J. PMID: 42248667 [PubMed - as supplied by publisher]
	Impact of arid-zone abiotic stress on phytochemical bioactivity: Enhancing chemotherapeutic synergy in breast cancer and personalized therapeutic algorithms. Fitoterapia Abdelazim A, Abdelgawad A, Eladl O. PMID: 42248478 [PubMed - as supplied by publisher]
	Clinicopathological response and survival outcomes of HER2-low versus HER2-zero early breast Cancer: A systematic review and Meta-analysis. Clin Chim Acta Liu L, Ma X, Liu C, Liu G, Zhang M, Wang T, Sun C. PMID: 42248318 [PubMed - as supplied by publisher]
	A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell death. Acta Biomater Wang J, Ahmed KS, Mao D, Shelling A, Jamieson S, Laking G, Porter D, Li J, Pan P, Nolan E, Feng N, Wu Z. PMID: 42248285 [PubMed - as supplied by publisher]
	Multimodal deep learning integration of clinical, dosiomics, and radiomics features to predict toxicity in breast cancer patients undergoing hypofractionated radiotherapy. Comput Biol Med Liu YT, Liu YC, Li YC, Chu KA, Huang ST, Tony Liang HK, Chang TA. PMID: 42248053 [PubMed - as supplied by publisher]
	Multi-regional transcriptomics reveals robust consensus subtypes beyond tumor heterogeneity of breast cancer. Transl Oncol Ji J, Zheng Q, Li X, Luo C, Wang J. PMID: 42247929 [PubMed - as supplied by publisher]
	The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants. Cancer Biol Ther Illindala R, Yang Y, Mandt T, Webster N, Steinmetz N, Newton I. PMID: 42247481 [PubMed - in process]
	Pre-analytical variables affecting breast cancer biomarker expression: A controlled single-specimen study of fixation duration, cold ischemia time, and fixative preparation in a low-resource setting. PLoS One Ndengue CP, Atangana PJA, Ateba GR, Mandengue SH, Mboudou ET, Eboumbou Moukoko CE. PMID: 42247401 [PubMed - in process]
	Accuracy of shear-wave elastography in diagnosing severity of breast cancer-related lymphedema. Ultrasound He H, Yu J, Xiang Y, Luo T, Tao S. PMID: 42245924 [PubMed - as supplied by publisher]
	ECG-derived PoincarÃ© plot graphical metrics for differentiating axillary lymph node metastasis in breast cancer. Front Physiol Fang N, Zhang A, Song Z, Xie Z, Shi B, Wang Z. PMID: 42245832 [PubMed]
	SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancer. Res Sq Warner AB, Solarz BB, Belyov M, Bolanos V, McCoy A, Fujii T, Lee JM, Conlon K, Gomez M, Redd B, Febres-Aldana CA, Xi L, Raffeld M, Patel R, Cordes L, Figg WD, Dinstag G, Aharonov R, Beker T, Aldape K, Ruppin E, Lipkowitz S, Rajagopal PS. PMID: 42245793 [PubMed]
	Diagnostic value of multimodal ultrasound imaging in triple-negative breast cancer. Front Oncol Wang F, Wang C, Wu J. PMID: 42245712 [PubMed]
	Current status of breast cancer diagnosis and treatment capacity in county-level medical institutions in Sichuan Province, China: a cross-sectional study. Front Oncol Kang L, Du C, Huang Y, Chen H, Tan X. PMID: 42245702 [PubMed]
	An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer. Front Immunol Chen Y, Lu X, Zhang L, Li Y, Chen H, Luo L, Pan Y, Gao B. PMID: 42245636 [PubMed - in process]
	Pinch and quadrants: a mechanical hypothesis for the site-specific incidence of breast cancer. Int J Clin Exp Pathol Wang D. PMID: 42244510 [PubMed]
	Effect of taxane-based adjuvant chemotherapy on breast cancer-related lymphedema: A propensity score matching study. Zhong Nan Da Xue Xue Bao Yi Xue Ban Kang D, Yan H, Lu Q, Chen H, Wang L. PMID: 42244317 [PubMed - in process]
	Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study. Int J Cancer Meijer J, Hermanns N, Bijlsma R, Blommestein HM, van den Bongard DHJG, van Dalen T, van Diest PJ, Drukker CA, Paez CG, Honkoop AH, Jager A, Koppert LB, Linn SC, van Maaren MC, Siemerink EJ, van 't LJ, Volders JH, Vrancken Peeters MJ, Siesling S. PMID: 42244246 [PubMed - as supplied by publisher]
	Safety assessment of autologous ovarian tissue cryopreservation and transplantation in cancer patients: an updated review. J Ovarian Res Wang L, Chu Y, Xie J, Chen J, Liu Y, Yang S, Zhang Y, Yue J. PMID: 42244015 [PubMed - as supplied by publisher]

Articles 1 - 20 / 329702

Page 1 of 16486



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy